PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.35%
Positive revenue growth while 6203.T is negative. John Neff might see a notable competitive edge here.
-3.36%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-38.35%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-18.20%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-55.37%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-55.32%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-55.32%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-93.11%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-26.07%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-7.29%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
92.77%
Net income/share CAGR at 50-75% of 6203.T's 137.96%. Martin Whitman might question if the firm’s product or cost base lags behind.
-2690.48%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-152.21%
Negative 3Y CAGR while 6203.T is 522.07%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
52.20%
Positive 5Y equity/share CAGR while 6203.T is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
35.88%
Positive short-term equity growth while 6203.T is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.62%
Firm’s AR is declining while 6203.T shows 1.78%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
12.04%
Inventory growth well above 6203.T's 12.31%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.21%
Asset growth above 1.5x 6203.T's 0.36%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-3.64%
We have a declining book value while 6203.T shows 1.86%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
9.70%
We have some new debt while 6203.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Our R&D shrinks while 6203.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.92%
We expand SG&A while 6203.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.